Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
Correction: Which method is optimal for estimating variance components and their variability in generalizability theory? Evidence from a set of unified rules for bootstrap method. [PDF]
Li G.
europepmc +1 more source
The Rule of Probabilities: A Practical Approach for Applying Bayes' Rule to the Analysis of DNA Evidence [PDF]
Ian Ayres, Barry Nalebuff
openalex
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang +8 more
wiley +1 more source
Biomarkers and clinical rules for the management of mild traumatic brain injury: a narrative review. [PDF]
Salgado S +5 more
europepmc +1 more source
Screening for lung cancer: A systematic review of overdiagnosis and its implications
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz +12 more
wiley +1 more source
Plyometric Performance in U13 Basketball: Influence of Modified Competitions and Maturational Status with GPS Tracking. [PDF]
Aguiar RAB +3 more
europepmc +1 more source
Justice of the Peace?: Why Federal Rule of Evidence 404(A)(2)(C) Should Be Repealed
Colin Miller
openalex +1 more source
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece +18 more
wiley +1 more source

